Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
326.80    -8.60 (-2.56%)
Bid:
326.00
Ask:
327.60
Spread: 1.60 (0.491%)
Market Cap: £715.92m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Trading Update

24 Jan 2013 07:00

RNS Number : 2487W
Burford Capital
24 January 2013
 



 

 

24 January 2013

 

BURFORD CAPITAL REPORTS SIGNIFICANT PROGRESS IN 2012

 

Record Year For Investment Recoveries

 

Burford Capital Limited ("Burford" or the "Company") is pleased to provide the following update on 2012 activity in advance of the release of its audited financial statements. The information in this IMS is as of 31 December 2012 and covers the fiscal year 2012.1

 

Summary

 

Burford demonstrated strong performance in 2012 with significant investment progress and a real maturation of the business. Neither Burford nor litigation finance is nascent any longer: Burford has evolved into a full-fledged, internally managed finance and investment business with multiple lines of business, multi-jurisdictional operations and compelling returns.

 

In 2012:

·; Burford generated investment recoveries of $47 million on a gross basis and $18 million net of invested capital - a 61% net return on invested capital

·; At year-end, a further $53 million in gross investment recoveries and $19 million in net investment recoveries were pending - a 55% net return on invested capital

·; Firstassist also performed strongly and contributed $11 million of EBITDA for its ten months in 2012 under Burford's ownership; Firstassist's overall 2012 performance was more than 35% ahead of the prior year

·; Burford also generated a further $9 million in net income from its portfolio financing and cash management activities

·; Burford continued active investing in 2012 based on its strong pipeline, making $72 million in new commitments to nine new investments

 

Since inception:

·; Burford has generated investment recoveries of $93 million on a gross basis and $35 million net of invested capital - a 61% net return on invested capital

·; Including pending matters, Burford stands at $147 million in gross investment recoveries and $54 million in net investment recoveries - a 59% net return on invested capital

·; Burford has committed $373 million to investments

 

Investment portfolio performance

 

Burford experienced material portfolio activity in 2012 that demonstrated the quality of its investment decisions and the vibrancy of its investment model. While the majority of Burford's investments have yet to reach maturity and contribute to performance, a significant minority of investments has now shown results and Burford has achieved consistent returns on invested capital of approximately 60%, net of losses and before operating expenses. Burford looks forward to 2013, when it expects further substantial portfolio activity.

 

Since inception, 18 investments have generated $93 million in gross investment recoveries 2 and $35 million net of invested capital, producing a 61% net return on invested capital.

 

In 2012 alone, 12 investments produced $47 million in gross investment recoveries and $18 million net of invested capital - likewise a 61% net return on invested capital. The acceleration in portfolio activity in 2012 is noteworthy: 2012 alone produced as much in investment recoveries as the two preceding years combined.

 

In addition to those investment recoveries, Burford has seven investments where trial or some initial adjudication has been completed but further proceedings remain, such as an appeal. If all such investments produce investment recoveries at the level awarded following trial or initial adjudication, Burford would have received at 31 December 2012 an additional $53 million in gross investment recoveries and $19 million net of invested capital - a 55% net return on invested capital.

 

All of the foregoing figures are net of investment losses and before operating expenses, including, in the case of the immediately preceding paragraph, losses that remain subject to appeal or further proceedings. As Burford has commented before, losses are an expected and inevitable aspect of our portfolio approach to litigation investing.

 

We make special mention of the Arizona real estate matter first announced in 2010. Matters have now progressed and, in short, Burford expects to generate a net return on invested capital in this matter of close to 250%. The matter enjoyed a large favorable jury verdict in 2010 (along with a settlement with a secondary defendant in 2010 on account of which Burford received a $4 million cash payment) and a settlement in 2011 which caused assets to be conveyed to the plaintiff and Burford's recognition of further income in 2011. In 2012, Burford's interest in the land in issue was converted to a secured debt instrument with a current face value of a further $15.5 million; that mortgage bears interest running at a blended rate of 23% and has an ultimate face value of $50 million at maturity in 2016, although earlier payment is expected.

 

Burford will provide further commentary on the investment portfolio in its annual report but it remains very pleased with the performance of the portfolio and its future prospects.

 

Firstassist performance 3

 

Since Burford completed the acquisition of Firstassist on 29 February 2012, it has performed above budget and generated more than $11 million in EBITDA. Indeed, for the full fiscal year, Firstassist generated more than $14 million in EBITDA, an increase of more than 35% over the prior year. In addition to growing its leading litigation expenses insurance business, Firstassist launched a UK litigation funding business in 2012 and embarked on a series of initiatives to prepare itself and its clients for the implementation of the Jackson reforms in April 2013.

 

The strength of Firstassist's performance to date and the size of its pool of pending cases made it likely that the earn-out provided for at the time of Burford's acquisition of Firstassist would be payable. Thus, Burford negotiated an early payment of the earn-out in exchange for a substantial discount - more than $2 million - and therefore now owns Firstassist outright with no contingent future payments and no minority shareholders.

 

Burford is soon to receive a dividend from the cash generated by Firstassist's operations to date in an amount in excess of $11 million.

 

Clearly, the Firstassist acquisition has been an unqualified financial success in addition to the substantial strategic benefits it has brought to Burford.

 

Other income performance

 

Burford's cash management and litigation portfolio advances activities produced income of approximately $9 million in 2012. That income covered a significant part of Burford's operating expenses.

 

Capital commitment and deployment

 

Since inception, Burford has committed $373 million of capital to 46 investments:

 

Commitment Amount ($mm)

Number of Investments

Short duration portfolio

64

13

Core portfolio

223

28

Special situations portfolio

27

3

Other investments

59

2

Total

373

46

 

At 31 December 2012, Burford's outstanding commitments were as follows:

 

Commitment Amount ($mm)

Number of Investments

Short duration portfolio

27

5

Core portfolio

195

21

Special situations portfolio

9

2

Other investments

59

2

Total

289

30

 

During 2012, Burford continued actively to make new investments, and committed $72 million to nine new investments. Burford expects to continue actively investing in 2013. Burford is experiencing regular turnover in the portfolio as well as meaningful earnings from non-portfolio sources, freeing up previous commitments to reinvest.

 

Stand-by capital

 

As we informed shareholders in November, Burford is presently exploring an innovative stand-by capital arrangement. The Company does not intend to draw on such a facility as a source of operating leverage but views it as a conservative precaution to address the potential for uncertainty in the timing and funding of investments. Burford continues to consult shareholders on both the structure and ultimate adoption of such a facility, and there can be no guarantee that one will be finalised.

 

1 This information has not been audited or otherwise reviewed by the Company's auditors and is presented using non-IFRS measures. The Company disclaims any obligation to update, amend or correct this information.

2 Burford is beginning here the use of the term "investment recoveries". We use that term to encompass: (i) entirely concluded investments where Burford has received all proceeds to which it is entitled (net of any entirely concluded investment losses); (ii) investments where Burford has received some proceeds (for example, from a settlement with one party in a multi-party case) but where the investment is continuing with the possibility of receiving additional proceeds; and (iii) investments where the underlying litigation has been resolved and there is a promise to pay proceeds in the future (for example, in a settlement that is to be paid over time) and there is no longer any litigation risk involved in the investment. When we express returns, we do so assuming all investment recoveries are paid currently, discounting back future payments as appropriate. We do not include wins or other successes where there remains litigation risk in the definition of "investment recoveries"; we report those separately as pending matters.

3 Financial results provided here for Firstassist are based on unaudited management reporting prepared shortly after yearend and remain subject to further change and adjustment.

 

Release of annual results

 

Burford plans to release its audited financial statements and accompanying report and commentary on 11 April 2013. We will provide further details about the investment portfolio's performance and composition at that time.

 

For further information, please contact:

 

Burford Capital

Elizabeth O'Connell +1 212 235 6825

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

 

Espirito Santo Investment Bank - Joint Broker

Richard Crawley +44 (0)20 7456 9191

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0) 20 7653 4000

James Kelly

 

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 7269 7297

Laura Ewart +44 (0)20 7269 7243

 

About Burford

 

Burford is the world's largest provider of investment capital and risk solutions for litigation with more than $300 million in capital and the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world. 

 

For more information about Burford: www.burfordcapital.com.

 

 

 

 

This document does not constitute an offer of securities for sale in the United States or in any other jurisdiction. The securities mentioned in this document may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended. There is no intention to register securities, or any offering or placement thereof, in the United States or to conduct a public offering of securities in the United States. The Company has not been registered under the United States Investment Company Act of 1940, as amended.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEANFDAFFDEFF
Date   Source Headline
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.